Kumar Prabhash

19PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 22, 2026
CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer.

|Jul 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in THRA, a Potential Modifier of Cellular Plasticity.

Vaishakhi Trivedi, Vanita Noronha, Munita Bal

|May 16, 2024
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.

Kumar Prabhash, Elveera Saldanha, Vijay Patil

|Mar 15, 2024
Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome.

Sanket Desai, Suhail Ahmad, Bhargavi Bawaskar

|Mar 04, 2024
Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications.

Bhasker Dharavath, Ashwin Butle, Akshita Chaudhary

|Feb 23, 2024
Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment.

Rohan Chaubal, Nilesh Gardi, Shalaka Joshi

Pageof 4

Frequent Collaborators

3 joint publications

Sudeep Gupta

3 joint publications

Nandini Menon

3 joint publications

Vijay Patil

3 joint publications

Vanita Noronha